华纳药厂 (688799.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 5.79B

MomentumView details →

1D Return

−0.73%

YTD Return

—

RSI (14)

61.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 5.79B

RSI (14)

61.0

MomentumView details →

1D Return

−0.73%

YTD Return

—

ProfitabilityView details →

Gross Margin

58.97%

Net Margin

15.00%

EBITDA Margin

21.26%

ROE (TTM)

10.79%

ROA (TTM)

6.91%

Asset Turnover

0.47x

GrowthView details →

Revenue YoY

+8.45%

EPS YoY

+53.89%

FCF YoY

−66.19%

Revenue CAGR 3Y

+5.18%

EPS CAGR 3Y

−2.45%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.29

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

−14.47%

Capital & dividendView details →

Debt/Equity

0.32x

Current Ratio

2.83x

Quick Ratio

1.83x

Div Yield

0.36%

Div Rate

CNY 0.18

Div Growth 1Y

−58.28%

Financials snapshotView financials →

Revenue (TTM)

1.49B

Net Income (TTM)

223.94M

Op. CF (TTM)

331.74M

Latest newsMore news →

Warner Pharmaceutical received a drug registration certificate approved by the National Medical Products Administration for Loxoprofen Sodium Patch, used for anti-inflammatory and analgesic purposes, available in two specifications.4d ago

Hua Na Pharmaceutical increased the investment budget for its wholly-owned subsidiary Zhigen Pharmaceutical's Phase I high-end API and intermediate green manufacturing base project from no more than 650 million yuan to no more than 800 million yuan.11d ago

Similar companies

津药药业600488.SH Amneal Pharmaceuticals, Inc.AMRX 辰欣药业603367.SH Shenzhen Hepalink Pharmaceutical Group Co., Ltd.09989.HK China Shineway Pharmaceutical Group Limited02877.HK 人民同泰600829.SH Find similar companies →

Latest newsMore news →

Warner Pharmaceutical received a drug registration certificate approved by the National Medical Products Administration for Loxoprofen Sodium Patch, used for anti-inflammatory and analgesic purposes, available in two specifications.4d ago Hua Na Pharmaceutical increased the investment budget for its wholly-owned subsidiary Zhigen Pharmaceutical's Phase I high-end API and intermediate green manufacturing base project from no more than 650 million yuan to no more than 800 million yuan.11d ago